You searched for Antibody candidate - Page 7 of 67

Best in Biotech 16 Apr 2024

Seven biotech companies climbing their way up in Colorado

…Therapeutics’ lead candidate is a PI3K inhibitor. PI3K is the most commonly mutated oncogene in cancer, particularly in estrogen receptor (ER)-positive breast cancer. The candidate OKI-219 works by hindering the…

April 16, 2024 - 8 minutesmins - By Roohi Mariam Peter

Best in Biotech 25 Mar 2025

These 7 biotechs are shaping the next generation of endometriosis care

…seven companies advancing promising candidates in the clinic. Table of contents Ananda Pharma Location: U.K. Drug candidate: MRX1 Technology: cannabidiol U.K.-based company Ananda Pharma is conducting a pilot randomized controlled…

March 25, 2025 - 9 minutesmins - By Roohi Mariam Peter

News and Trends 12 Dec 2018

Antibody Hitting Tumor Self-Destruct Button Passes Phase I

…antibody met the trial’s primary objective of good tolerability in the 19 recruited patients. In addition, the antibody helped to stabilize the disease and shrink tumors in patients with uterine…

December 12, 2018 - 2 minutesmins - By Jonathan Smith

Expert Advice 11 Dec 2019

What Makes a Successful Biotech?

…called Cambridge Antibody Technology. Almost 10 years later, the company’s antibody drug Humira — now the world’s best selling drug — was approved by the US FDA to treat rheumatoid…

December 11, 2019 - 12 minutesmins - By Helen Albert

News and Trends 12 Dec 2022

Antibody discovery could lead to new therapies to tackle Strep A

Researchers at Lund University in Sweden have discovered an antibody with the potential to protect against Strep A infection, as well as a rare form of antibody binding, that leads…

December 12, 2022 - 4 minutesmins - By Jim Cornall

Morphosys Janssen Guselkumab approval psoriasis

News and Trends 18 Sep 2017

Update: After 25 years, MorphoSys Gets its First Antibody Approved

…psoriasis, bringing the first antibody developed by MorphoSys to the market. After celebrating its 25th anniversary last week, MorphoSys is welcoming the approval of the first antibody developed using its…

September 18, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 1 Nov 2016

This Technology could Open Up a new 4th Generation of Therapeutic Antibodies

…of all therapeutic antibody generations (those with the antibody icon are available at BIOTEM) So how are optimal 4th-gen antibodies developed? 1. Low immunogenicity A foreign antibody can induce an…

November 1, 2016 - 5 minutesmins - By External Contributor

News and Trends 23 Nov 2022

Concern as study says new covid sub-variant is resistant to all therapeutic antibodies

…a new antibody therapy that is about to be approved in the U.S. highlights the importance of developing new antibody therapies against Covid-19. “The ever-increasing development of antibody resistance of…

November 23, 2022 - 4 minutesmins - By Jim Cornall

News and Trends 22 Mar 2017

What’s the Gold Standard for Therapeutic Antibodies?

…counts with billions of naturally human antibodies within its universal antibody libraries. Within six weeks, Yumab can sort through billions of candidates to obtain between 10 and 1000 hits with…

March 22, 2017 - 4 minutesmins - By External Contributor

David Chiswell interview Kymab Antibodies

Interview 18 Sep 2017

David Chiswell: “We are getting close to the best way of making antibodies”

…Chiswell was, along with Greg Winter, one of the co-founders of Cambridge Antibody Technology. “We both wanted to start an antibody company,” says Chiswell. “And if you have an opportunity…

September 18, 2017 - 4 minutesmins - By Clara Rodríguez Fernández

News and Trends 2 Apr 2025

Top biotech deals of March 2025

…cell engager. The clinical candidate DR-0201 is an antibody that targets and engages specific myeloid cells – immune cells that originate in the bone marrow – to induce deep B-cell…

April 2, 2025 - 9 minutesmins - By Roohi Mariam Peter

News and Trends 22 Jun 2023

Alchemab Therapeutics unveils Alzheimer’s candidate

Alchemab Therapeutics, an antibody discovery company identifying naturally occurring antibodies from individuals resilient to disease, has unveiled data on ATLX-1088, its newly-discovered preclinical Alzheimer’s candidate, at the Antibody Industrial Symposium…

June 22, 2023 - 3 minutesmins - By Jim Cornall

Knowledge hub

Categories

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Antibody candidate

Seven biotech companies climbing their way up in Colorado

These 7 biotechs are shaping the next generation of endometriosis care

Antibody Hitting Tumor Self-Destruct Button Passes Phase I

What Makes a Successful Biotech?

Antibody discovery could lead to new therapies to tackle Strep A

Update: After 25 years, MorphoSys Gets its First Antibody Approved

This Technology could Open Up a new 4th Generation of Therapeutic Antibodies

Concern as study says new covid sub-variant is resistant to all therapeutic antibodies

What’s the Gold Standard for Therapeutic Antibodies?

David Chiswell: “We are getting close to the best way of making antibodies”

Top biotech deals of March 2025

Alchemab Therapeutics unveils Alzheimer’s candidate

Subscribe to our newsletter to get the latest biotech news!

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!